SiteOne Therapeutics
Latest round
- Series C
Last raised
- Dec 2024
Total raised
- $116M
Investors
- 12
About SiteOne Therapeutics
Founded in 2010, SiteOne Therapeutics, Inc. operates as a biomedical company dedicated to developing therapies for sensory hyperexcitability disorders. The company has undergone strategic pivots to enhance its focus on targeted small molecule ion channel modulators.60 mn.SiteOne Therapeutics specializes in developing innovative therapeutic solutions for unmet medical needs in the healthcare sector. The company primarily offers advanced drug delivery systems and targeted therapies aimed at enhancing treatment efficacy for chronic pain and neurological disorders.SiteOne Therapeutics generates revenue through a structured business model that includes partnerships with healthcare providers, wholesalers, and direct-to-consumer sales channels. The firm engages in B2B transactions, supplying core therapeutic products to hospitals and clinics while exploring subscription models for ongoing access to their therapies.00 mn secured on December 18, 2024, SiteOne Therapeutics plans to advance its innovative range of targeted, small molecule ion channel modulators aimed at treating sensory hyperexcitability disorders through essential human clinical validation.
Who invested in SiteOne Therapeutics
12 investors across 3 rounds
See all investors in SiteOne Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SiteOne Therapeutics
Who invested in SiteOne Therapeutics?
SiteOne Therapeutics has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SiteOne Therapeutics raised?
SiteOne Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did SiteOne Therapeutics last raise money?
SiteOne Therapeutics's most recent round on record is a Series C, in Dec 2024.
What does SiteOne Therapeutics do?
Founded in 2010, SiteOne Therapeutics, Inc.
Where is SiteOne Therapeutics headquartered?
SiteOne Therapeutics is headquartered in South San Francisco, US.
Which VCs invest in companies like SiteOne Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at SiteOne Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like SiteOne Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.